Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. As an inventor company, we set trends in research-intensive areas. Our products and services are designed to benefit people and improve their quality of life. At the same time we aim to create value through innovation, growth and high earning power. We are committed to the principles of sustainable development and to our social and ethical responsibilities as a corporate citizen.
We have set out to create an enterprise that is keenly focused on its customers, its strengths, its potential and the markets of the future: a top international company renowned for product quality, employee skills, economic performance and innovative strength, and committed to increasing corporate value and achieving sustained growth. The Bayer brand symbolizes these goals throughout the world.
To sharpen our focus on innovation and growth, we have carried out a strategic realignment, placing our businesses into three subgroups that operate virtually independently and are fully aligned to their respective markets. They are supported by competent service companies. With our distinctive knowledge of people, animals, plants and materials, we intend to focus in future on the areas of
By applying our skills in these areas we aim to
These activities offer access to major growth markets. This mission statement underscores our willingness as an inventor company to help shape the future and our determination to come up with innovations that benefit humankind.
Of special importance in this respect are:
Bayer is an inventor company infused with a pioneering spirit. We invest extensively in technology because innovation is the foundation for competitiveness and growth, and thus for our future success. By focusing our resources on the expanding areas of our innovative HealthCare, CropScience and MaterialScience businesses, we lay the foundations for sustained, longterm growth in future markets. We believe synergistic potential exists in the use of our technologies by more than one of our subgroups.
Here we draw on the expertise that our scientists have acquired over decades of interdisciplinary research. Innovative applications for biotechnology and nanotechnology also hold promise for us in the future.
Supplementing the subgroups’ targeted R&D activities is our subsidiary Bayer Innovation GmbH, set up specifically to turn innovative project ideas into new business concepts. This company not only looks at individual products but also seeks to open up new business opportunities, such as those offered by the combination of materials and active substances in medical applications, or the continuing development of optical data storage media for security systems.
Another core element of our corporate strategy is rigorous value management. Our performance-related compensation systems reward and incentivize the achievement of our value-creation targets.
Portfolio management will continue to play a crucial role in the Bayer Group. We aim to continue improving our market positions through strategic acquisitions and alliances. We will divest activities that in the long term are unlikely to yield a return exceeding their capital costs.
